Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Sarcoma 17Rhabdomyosarcoma 14Wilms Tumor 9Malignant mesenchymal tumor 7Gestational Trophoblastic Disease 6Kidney Neoplasms 5Neuroectodermal Tumors, Primitive, Peripheral 4Rhabdomyosarcoma, Embryonal 3Melanoma 3Fibrosarcoma 3Sarcoma, Ewing 2Rhabdomyosarcoma, Alveolar 2Ovarian Neoplasms 2Liposarcoma 2Hydatidiform Mole 2Hemangiosarcoma 2Hemangiopericytoma, Malignant 2Desmoplastic Small Round Cell Tumor 2Choriocarcinoma 2Testicular Neoplasms 1Teratoma, Ovarian 1Stage I Mixed Cell Type Kidney Wilms Tumor 1Sarcoma, Alveolar Soft Part 1Rhabdoid Tumor 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pleuropulmonary blastoma 1Neoplasms, Germ Cell and Embryonal 1Neoplasms 1Lymphoma 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1

Interventions

pembrolizumab 185Gemcitabine 170Paclitaxel 152Carboplatin 137Bevacizumab 128Surveys and Questionnaires 118Cisplatin 115Docetaxel 114Blood Specimen Collection 110Cyclophosphamide 109Exercise 108Nivolumab 98Fluorouracil 90Capecitabine 86Dexamethasone 81Radiotherapy 80Irinotecan 74Standard of Care 69Pemetrexed 68Oxaliplatin 68Leucovorin 64Drug Therapy 64Cetuximab 60Erlotinib Hydrochloride 56Sorafenib 53atezolizumab 52Ipilimumab 51Doxorubicin 50trametinib 47Interviews as Topic 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms × Dactinomycin × Clear all
NCT00491946 2007-06-26

A Pharmacokinetic Study of Actinomycin-D and Vincristine in Children With Cancer

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Phase 4 Unknown
24 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡